14-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.BETA.-METHYL-8.ALPHA.,9.BETA.,14.BETA.-PREGNA-1,4-DIENE-3,20-DIONE
UNII D5P9N1W189
Substance Identification & Data
This profile provides standardized clinical and technical data for 14-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methyl-8.alpha.,9.beta.,14.beta.-pregna-1,4-diene-3,20-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D5P9N1W189.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 185613-71-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H29FO5 OXYIPQGDQCLIAE-RNGLRLRGSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 14-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methyl-8.alpha.,9.beta.,14.beta.-pregna-1,4-diene-3,20-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.